Left main coronary artery disease: is CABG still the gold standard?

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Medical Technology

Background:

• Severe left main coronary artery (LMCA) stenosis is a critical condition with significant prognostic implications.
• Coronary artery bypass grafting (CABG) has been the standard treatment for LMCA disease for decades due to its survival advantage.
• Percutaneous coronary intervention (PCI) was historically associated with poor outcomes for LMCA stenosis, leading to its contraindication.

Purpose of the Study:

• To review the natural history of LMCA disease.
• To compare outcomes of CABG versus PCI for LMCA disease.
• To highlight recent advancements in PCI, particularly drug-eluting stents, for LMCA treatment.

Main Methods:

• Review of the natural history of left main coronary artery disease.
• Analysis of outcomes data for coronary artery bypass grafting (CABG) in LMCA disease.
• Evaluation of historical and recent studies on percutaneous coronary intervention (PCI) for LMCA disease, including drug-eluting stent outcomes.

Main Results:

• Recent studies utilizing sirolimus- and/or paclitaxel-eluting stents for LMCA disease show favorable in-hospital and 1-year mortality rates.
• These outcomes for PCI with drug-eluting stents appear comparable to those achieved with CABG.
• Advancements in stenting technology have revived interest in PCI as a treatment option for LMCA stenosis.

Conclusions:

• Percutaneous coronary intervention (PCI) with drug-eluting stents is emerging as a safe and effective alternative to CABG for severe LMCA stenosis.
• The improved outcomes with modern PCI techniques challenge the long-standing paradigm of CABG as the sole revascularization strategy for LMCA disease.
• Further evaluation of long-term outcomes is essential to fully establish the role of PCI in managing LMCA disease.